Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bayer Aktienges ADR (BAYRY)

Bayer Aktienges ADR (BAYRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
ORIC: Working with Two Pharma Giants, Analysts See +100% Upside

ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.

BAYRY : 5.1400 (-4.10%)
JNJ : 153.42 (+0.20%)
ORIC : 8.74 (unch)
PFE : 24.85 (-0.36%)
Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback

The third-quarter earnings season came to an end this week for large drugmakers, with AstraZeneca AZN and Bayer BAYRY announcing their results. AbbVie’s ABBV schizophrenia candidate, added from a recent...

BAYRY : 5.1400 (-4.10%)
AZN : 63.71 (+0.81%)
JNJ : 153.42 (+0.20%)
MRK : 97.49 (+0.05%)
ABBV : 168.23 (+0.28%)
Bayer Q3 Earnings Miss Estimates, Nubeqa, Kerendia Boost Sales

Bayer AG BAYRY reported third-quarter 2024 core earnings of 7 cents per American Depositary Receipt (ADR), which missed the Zacks Consensus Estimate of 17 cents. The company reported earnings of 10 cents...

BAYRY : 5.1400 (-4.10%)
JNJ : 153.42 (+0.20%)
REGN : 743.35 (-0.17%)
REGN Q3 Earnings and Revenues Beat on Strong Eylea HD & Dupixent Sales

Regeneron Pharmaceuticals, Inc. REGN reported better-than-expected third-quarter results despite lower sales from its lead drug, Eylea. Revenues climbed 11% to $3.72 billion, driven by growth in Eylea...

BAYRY : 5.1400 (-4.10%)
NVS : 103.11 (+0.02%)
REGN : 743.35 (-0.17%)
SNY : 47.64 (-0.29%)
Novartis Gets CHMP Recommendation for Kisqali in Broader Population

Novartis NVS announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (EMA) recommended granting approval to the breast cancer drug Kisqali (ribociclib)...

BAYRY : 5.1400 (-4.10%)
LLY : 753.00 (-0.05%)
NVS : 103.11 (+0.02%)
Bayer Seeks Approval for Elinzanetant for Vasomotor Symptoms in EU

Bayer BAYRY announced that it has submitted a marketing authorization application (MAA) to the European Medicines Agency (“EMA”) for its pipeline candidate elinzanetant.The MAA is seeking approval...

BAYRY : 5.1400 (-4.10%)
LLY : 753.00 (-0.05%)
NVS : 103.11 (+0.02%)
Roche Wins FDA Nod for Breast Cancer Drug in First-Line Setting

Roche RHHBY announced that the FDA has approved pipeline candidate, inavolisib, for the treatment of breast cancer, under the brand name Itovebi.The drug is approved in combination with Pfizer’s Ibrance...

BAYRY : 5.1400 (-4.10%)
NVS : 103.11 (+0.02%)
RHHBY : 35.1300 (-0.79%)
SNY : 47.64 (-0.29%)
Regeneron Gains 13.5% Year to date: How to Play the Stock?

Shares of Regeneron Pharmaceuticals, Inc. REGN have gained 13.5% in the year so far against the industry’s decline of 2.8%.The stock has outperformed the sector during this timeframe but underperformed...

BAYRY : 5.1400 (-4.10%)
REGN : 743.35 (-0.17%)
RHHBY : 35.1300 (-0.79%)
SNY : 47.64 (-0.29%)
Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer

For Immediate ReleaseChicago, IL – October 8, 2024 – Today, Zacks Equity Research Eli Lilly LLY, AstraZeneca AZN, Pfizer PFE, Sanofi SNY and Bayer BAYRY.Industry: Big PharmaLink: https://www.zacks.com/commentary/2346520/5-large-drug-stocks-to-watch-from-a-thriving-industryThe...

BAYRY : 5.1400 (-4.10%)
AZN : 63.71 (+0.81%)
LLY : 753.00 (-0.05%)
PFE : 24.85 (-0.36%)
SNY : 47.64 (-0.29%)
5 Large Drug Stocks to Watch From a Thriving Industry

The drug and biotech industry has done well this year, driven by increased mergers and acquisitions (M&A), the launch of promising new medicines and pipeline successes. Obesity drugs of Novo Nordisk and...

BAYRY : 5.1400 (-4.10%)
AZN : 63.71 (+0.81%)
LLY : 753.00 (-0.05%)
PFE : 24.85 (-0.36%)
SNY : 47.64 (-0.29%)

Barchart Exclusives

Is Apple Stock a Buy Now, or Should You Wait for a Dip?
Apple stock has underperformed markets in 2024. It might be worthwhile waiting for a dip in AAPL stock instead of rushing to buy at current price levels. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar